Stonepine Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50
| Closed | -$1.27K | – | 22 |
|
|
2023
Q1 | $1.27K | Buy |
+50
| New | +$1.27K | ﹤0.01% | 22 |
|
|
2022
Q3 | – | Sell |
-10,422
| Closed | -$102K | – | 21 |
|
|
2022
Q2 | $102K | Sell |
10,422
-114,404
| -92% | -$1.12M | 0.05% | 25 |
|
|
2022
Q1 | $2.08M | Buy |
124,826
+9,249
| +8% | +$154K | 0.86% | 23 |
|
|
2021
Q4 | $2.94M | Buy |
115,577
+76,436
| +195% | +$1.94M | 1.35% | 16 |
|
|
2021
Q3 | $1.75M | Sell |
39,141
-21,423
| -35% | -$960K | 0.8% | 20 |
|
|
2021
Q2 | $2.45M | Buy |
+60,564
| New | +$2.45M | 1.28% | 20 |
|
|
2020
Q2 | – | Sell |
-65,149
| Closed | -$3.23M | – | 16 |
|
|
2020
Q1 | $3.23M | Buy |
+65,149
| New | +$3.23M | 3.42% | 16 |
|
|
2018
Q4 | – | Sell |
-32,807
| Closed | -$2.89M | – | 24 |
|
|
2018
Q3 | $2.89M | Buy |
32,807
+11,530
| +54% | +$1.01M | 1.69% | 18 |
|
|
2018
Q2 | $2.21M | Buy |
+21,277
| New | +$2.21M | 1.34% | 19 |
|